CYBB and Alzheimer disease: Indeed, researchers are looking for inhibitors of NOX2 as a novel therapeutic class of drugs to treat diseases such as AD, PD, cardiovascular diseases, and many other diseases where oxidative stress and inflammation are key drivers.